Milestones

Inclusion in New Solactive Emerging Marijuana Growers Index
The Solactive Junior Marijuana Growers Index is designed to provide exposure to the performance of a basket of primarily North American publicly-listed small-capitalization companies primarily involved in the cultivation, production, and/or distribution of marijuana.

Liberty Leaf Common Shares Now DTC Eligible:
Means Faster, Easier Trading of Liberty Leaf Shares for Cannabis Sector Investors.

Liberty Leaf Acquires the Majority Interest in Just Kush:
– a Late-Stage ACMPR Applicant and a Company in Control of a Current MMAR-Licensed Facility. The acquisition puts two ACMPR licences in play, strengthening Liberty Leaf’s strategic position as a forward-thinking, vertically-integrated cannabis company.

Liberty Leaf Receives $763,500 from Exercise of Warrants:
We are very pleased with the level of support received from our shareholders as demonstrated by the recent exercise of warrants. With our significantly improved treasury, Liberty Leaf is well positioned to further advance its corporate initiatives.

North Road Ventures retains Cannabis Compliance Inc. to usher in Application Abridgement to Health Canada:
The abridgment will increase the authorized distribution capacity of the company, as well as add new products to its application. North Road Ventures was acquired by Liberty Leaf on October 19, 2016, and focuses on distributing high-quality medicinal cannabis.

Liberty Leaf In Collaboration With ESEV R&D Launches Study To Demonstrate the Efficacy of CBD for Pain Management in Canine Osteoarthritis
Liberty Leaf announced today that it has finalized the statement of work model and design for testing the efficacy of Cannabinoids (CBD) in canine osteoarthritis, which includes hip dysplasia, elbow dysplasia and stifle Degenerative Joint Disease (DJD).

Liberty Leaf is added to the CSE Composite Index,
a unique gauge of the Canadian small cap market. The index is comprised of listed company shares that meet market capitalization, trading and seasoning criteria established by the Exchange.

Liberty Leaf begins trading its common shares on the Frankfurt, Berlin, and Stuttgart Stock Exchanges
under the ticker symbol: HN3P and WKN: A2AT5C. These listings in provide the Company with increased exposure to some of the largest capital markets in the world and enable its European investor base to trade the Company’s common shares in their home currency.

Liberty Leaf receives an aggregate $650,325
from the exercise of share purchase warrants.

Weststar receives shareholder approval
on the fundamental change of business and closes a non-brokered private placement financing for gross proceeds of more than $370,000.

Weststar receives conditional approval from the Canadian Securities Exchange
on a Fundamental Change to the business concerning the purchase of North Road Ventures. The company also announces its intent to change its name to Liberty Leaf Holdings Ltd., and to change its stock symbol to “LIB”.

Weststar signs a definitive agreement to purchase shares of North Road Ventures Inc.,
a private British Columbia company, representing up to a 50% interest in North Road. This gives Weststar the opportunity to earn up to a 50% interest in North Road’s pending Marihuana for Medical Purposes Regulations (“MMPR”) application.

Weststar closes oversubscribed financing
of $509,000 towards concluding a deal to purchase North Road Ventures, a company actively seeking a Health Canada Producer’s Licence. Note: as of 2017, producer licences are estimated to be worth $50 million.